Across TCGA pan-cancer cohorts, PRR29 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PRR29 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher PRR29 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRR29 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD and UCEC are the cancer types where PRR29 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	IV	0.342	0.893	<.001	12	view →
UCEC	DFS	Median	All	1.000	0.830	.029	8	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: PRR29 tumor-vs-normal RNA expression · all PRR29 data types